Deborah Bilder,
MD
No Rating Available?
0
out of
5
Patient Rating
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the
minimum.
Languages Spoken: English, German
Deborah Bilder, MD, is a Professor in the Department of Psychiatry in the Division of Child and Adolescent Psychiatry at the University of Utah. She also holds adjunct appointments in the departments of Pediatrics and Educational Psychology. She completed the triple board residency program (Pediatrics, General Psychiatry, Child & Adolescent Psychiatry) at the University of Utah and maintains board certification in all three specialties. Following residency, she participated in the Utah Regional Leadership Education in Neurodevelopmental and Related Disabilities (URLEND) and is now a consultant for this program.
Through her leadership, she facilitated the growth of Neurobehavior HOME program, a fiscally viable, Medicaid-funded sub-specialty medical home program for individuals throughout the lifespan with neurodevelopmental disabilities. She is a clinical and research expert in autism and is the Principal Investigator for the Utah Registry of Autism and Developmental Disabilities and Co-Principal Investigator for the Utah site of the Centers for Disease Control and Prevention’s Autism and Developmental Disabilities Monitoring Network. She consults for pharmaceutical companies on clinical trial protocol development for drugs and biologics that target rare genetic conditions.
Clinical Locations
UNI Neurobehavior HOME Program
801-581-5515
Board Certification and Academic Information
| Academic Departments | Psychiatry
-
Professor (Clinical) Educational Psychology - Adjunct Associate Professor Pediatrics - Adjunct Professor |
| Academic Divisions | Child Psychiatry General Pediatrics |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry) American Board of Psychiatry & Neurology (Psychiatry) |
Deborah Bilder, MD, is a Professor in the Department of Psychiatry in the Division of Child and Adolescent Psychiatry at the University of Utah. She also holds adjunct appointments in the departments of Pediatrics and Educational Psychology. She completed the triple board residency program (Pediatrics, General Psychiatry, Child & Adolescent Psychiatry) at the University of Utah and maintains board certification in all three specialties. Following residency, she participated in the Utah Regional Leadership Education in Neurodevelopmental and Related Disabilities (URLEND) and is now a consultant for this program.
Through her leadership, she facilitated the growth of Neurobehavior HOME program, a fiscally viable, Medicaid-funded sub-specialty medical home program for individuals throughout the lifespan with neurodevelopmental disabilities. She is a clinical and research expert in autism and is the Principal Investigator for the Utah Registry of Autism and Developmental Disabilities and Co-Principal Investigator for the Utah site of the Centers for Disease Control and Prevention’s Autism and Developmental Disabilities Monitoring Network. She consults for pharmaceutical companies on clinical trial protocol development for drugs and biologics that target rare genetic conditions.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Psychiatry
-
Professor (Clinical) Educational Psychology - Adjunct Associate Professor Pediatrics - Adjunct Professor |
| Academic Divisions | Child Psychiatry General Pediatrics |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry) American Board of Psychiatry & Neurology (Psychiatry) |
Education History
| Certification | University of Utah David Eccles School of Business Business Certification, 2018 |
| Other Training | Utah Leadership Education in Neurodevelopmental Disabilities Pediatrics Certification, 2004 |
| Residency | University of Utah School of Medicine Triple Board Resident, 2003 |
| Internship | University of Utah School of Medicine Triple Board Intern, 1999 |
| Professional Medical | Vanderbilt University Medicine M.D., 1998 |
| Undergraduate | Wake Forest University School of Medicine German B.A., 1994 |
Selected Publications - Journal Articles
Journal Article
- Lyall K, Ning X, Aschner JL, Avalos LA, Bennett DH, Bilder DA, Bush NR, Carroll KN, Chu SH, Croen LA, Dabelea D, Daniels JL, Duarte C, Elliott AJ, Fallin MD, Ferrara A, Hertz-Picciotto I, Hipwell AE, Jensen ET, Johnson SL, Joseph RM, Karagas M, Kelly RS, Lester BM, Margolis A, McEvoy CT, Messinger D, Neiderhiser JM, OConnor TG, Oken E, Sathyanarayana S, Schmidt RJ, Sheinkopf SJ, Talge NM, Turi KN, Wright RJ, Zhao Q, Newschaffer C, Volk HE, Ladd-Acosta C, Environmental Influences On Child Health Outcomes OBOPCF (2022). Cardiometabolic Pregnancy Complications in Association with Autism-Related Traits as Measured by the Social Responsiveness Scale in ECHO. Am J Epidemiol.
- Bilder DA, Arnold GL, Dimmock D, Grant ML, Janzen D, Longo N, Nguyen-Driver M, Jurecki E, Merilainen M, Amato G, Waisbren S (2021). Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria. Am J Med Genet A, 188(3), 768-778.
- Kirby AV, Bilder DA, Wiggins LD, Hughes MM, Davis J, Hall-Lande JA, Lee LC, McMahon WM, Bakian AV (2022). Sensory features in autism: Findings from a large population-based surveillance system. Autism Res, 15, 751-760.
- Burton BK, Skalicky A, Baerwald C, Bilder DA, Harding CO, Ilan AB, Jurecki E, Longo N, Madden DT, Sivri HS, Wilcox G, Thomas J, Delaney K (2021). A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials. Mol Genet Metab Rep, 29, 100810.
- Juand-Prats C, James E, Bilder DA, McNair L, Kenneally N, Helfer J, Huang N, Vila MC, Sullivan J, Wirrell E, Rico S (2021). DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research. Epilepsy Behav, 122, 108198.
- Lloyd A, Aggio D, Slocomb TL, Lee J, Beggs AH, Bilder D (2021). Estimation of the Quality-of-Life Impact of X-Linked Myotubular Myopathy. J Neuromuscul Dis, 8, 1047-1061.
- Worsham W, Dalton S, Bilder DA (2021). The Prenatal Hormone Milieu in Autism Spectrum Disorder. Front Psychiatry, 12, 655438.
- Patrick ME, Shaw KA, Dietz PM, Baio J, Yeargin-Allsopp M, Bilder DA, Kirby RS, Hall-Lande JA, Harrington RA, Lee LC, Lopez MLC, Daniels J, Maenner MJ (2020). Prevalence of intellectual disability among eight-year-old children from selected communities in the United States, 2014. Disabil Health J, 14(2), 101023.
- Duong T, Harding G, Mannix S, Abel C, Phillips D, Alfano LN, Bnnemann CG, Lilien C, Lowes LP, Servais L, Warken-Madelung B, Nieto Bergman S, James ES, Noursalehi M, Prasad S, Rico S, Bilder DA (2020). Use of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance. J Neuromuscul Dis, 8(1), 63-77.
- Christ SE, Clocksin HE, Burton BK, Grant ML, Waisbren S, Paulin MC, Bilder DA, White DA, Saville C (2020). Executive function in phenylketonuria (PKU): Insights from the Behavior Rating Inventory of Executive Function (BRIEF) and a large sample of individuals with PKU. Neuropsychology, 34(4), 456-466.
- Bilder DA, Esplin MS, Coon H, Burghardt P, Clark EAS, Fraser A, Smith KR, Worsham W, Chappelle K, Rayner T, Bakian AV (2019). Early Second Trimester Maternal Serum Steroid-Related Biomarkers Associated with Autism Spectrum Disorder. J Autism Dev Disord, 49(11), 4572-4583.
- Longo N, Dimmock D, Levy H, Viau K, Bausell H, Bilder DA, Burton B, Gross C, Northrup H, Rohr F, Sacharow S, Sanchez-Valle A, Stuy M, Thomas J, Vockley J, Zori R, Harding CO (2018). Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. Genet Med, 21(8), 1851-1867.
- Christensen DL, Maenner MJ, Bilder D, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Pettygrove SD, Robinson C, Shenouda J, White T, Zahorodny W, Pazol K, Dietz P (2019). Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014. MMWR Surveill Summ, 68(2), 1-19.
- Kirby AV, Bakian AV, Zhang Y, Bilder DA, Keeshin BR, Coon H (2019). A 20-year study of suicide death in a statewide autism population. Autism Res, 12(4), 658-666.
- Christensen DL, Braun KVN, Baio J, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee LC, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M (2018). Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveill Summ, 65(13), 1-23.
- Bakian AV, Bilder DA, Korgenski EK, Bonkowsky JL (2018). Autism Spectrum Disorder and Neonatal Serum Magnesium Levels in Preterm Infants. Child Neurol Open, 5, 2329048X18800566.
- Thomas J, Levy H, Amato S, Vockley J, Zori R, Dimmock D, Harding CO, Bilder DA, Weng HH, Olbertz J, Merilainen M, Jiang J, Larimore K, Gupta S, Gu Z, Northrup H, PRISM investigators (2018). Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM). Mol Genet Metab, 124(1), 27-38.
- Farley M, Cottle KJ, Bilder D, Viskochil J, Coon H, McMahon W (2017). Mid-life social outcomes for a population-based sample of adults with ASD. Autism Res, 11(1), 142-152.
- Schoser B, Bilder DA, Dimmock D, Gupta D, James ES, Prasad S (2017). The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurol, 17(1), 202.
- Dickerson AS, Rahbar MH, Pearson DA, Kirby RS, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Zahorodny WM, Moy LA 3rd, Durkin M, Slay Wingate M (2017). Autism spectrum disorder reporting in lower socioeconomic neighborhoods. Autism, 21(4), 470-480.
- Bilder DA, Kobori JA, Cohen-Pfeffer JL, Johnson EM, Jurecki ER, Grant ML (2017). Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study. Mol Genet Metab, 121(1), 1-8.
- Bilder DA, Bakian AV, Stevenson DA, Carbone PS, Cunniff C, Goodman AB, McMahon WM, Fisher NP, Viskochil D (2016). Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network. J Autism Dev Disord, 46(10), 3369-76.
- Dickerson AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Kirby RS, Durkin MS, Han I, Moy LA 3rd, Pearson DA, Wingate MS, Zahorodny WM (2016). Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Environ Monit Assess, 188(7), 407.
- Jones KB, Cottle K, Bakian A, Farley M, Bilder D, Coon H, McMahon WM (2015). A description of medical conditions in adults with autism spectrum disorder: A follow-up of the 1980s Utah/UCLA Autism Epidemiologic Study. Autism, 20(5), 551-61.
- Wyrwich KW, Shaffer S, Gries K, Auguste P, Mooney KH, Prasad S, Bilder DA (2016). Content validity of the ADHD Rating Scale (ADHD RS-IV) and Adult ADHD Self-Report Scale (ASRS) in phenylketonuria. J Inborn Errors Metab Screen, 4, 1-9.
- Viau K, Jones JL, Murtaugh MA, Gren LH, Stanford JB, Bilder DA (2016). Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria. Mol Genet Metab Rep, 6, 27-33.
- Autism and Developmental Disabilities Monitoring Network Surveillance Year 2012 Principal Investigators (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years – Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill Summ, 65(3), 1-23.
- Ruiz LM, Damron M, Jones KB, Weedon D, Carbone PS, Bakian AV, Bilder DA (2016). Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home. J Autism Dev Disord, 46(6), 1887-1894.
- Bilder DA, Noel JK, Baker ER, Irish W, Chen Y, Merilainen MJ, Prasad S, Winslow BJ (2016). Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria. Dev Neuropsychol, 41(4), 245-260.
- Viau KS, Jones JL, Murtaugh MA, Gren LH, Stanford JB, Bilder DA (2016). Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria. Mol Genet Metab Rep, 6, 27-33.
- Gray DD, Bilder DA, Leonard HL, Anders TF (2006). Triple board training and new "portals" into child psychiatry training. Child Adolesc Psychiatr Clin N Am, 16(1), 55-66, viii.
Other
Video/Film/CD/Web/Podcast
- Bilder D, Lainhart J (2004). "Autism Module", Utah Collaborative Medical Home Project [Web]. Utah Collaborative Medical Home Project. Available: http://medhome.med.utah.edu/diag/diagnosis.cfm?diag_id=20&.
Patent
- (2018). Sources of Distress.